Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16778211rdf:typepubmed:Citationlld:pubmed
pubmed-article:16778211lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:16778211lifeskim:mentionsumls-concept:C0020517lld:lifeskim
pubmed-article:16778211lifeskim:mentionsumls-concept:C0035339lld:lifeskim
pubmed-article:16778211lifeskim:mentionsumls-concept:C1326205lld:lifeskim
pubmed-article:16778211lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:16778211lifeskim:mentionsumls-concept:C0040845lld:lifeskim
pubmed-article:16778211lifeskim:mentionsumls-concept:C0206142lld:lifeskim
pubmed-article:16778211lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:16778211pubmed:issue12lld:pubmed
pubmed-article:16778211pubmed:dateCreated2006-6-16lld:pubmed
pubmed-article:16778211pubmed:abstractTextHypereosinophilic syndrome (HES) has recently been recognized as a clonal leukemic lesion, which is due to a specific oncogenic event that generates hyperactive platelet-derived growth factor receptor-alpha-derived tyrosine kinase fusion proteins. In the present work, the effect of retinoids on the leukemic hypereosinophilia-derived EoL-1 cell line and on primary HES-derived cells has been investigated. We show that all-trans-retinoic acid (ATRA) inhibits eosinophil colony formation of HES-derived bone marrow cells and is a powerful inducer of apoptosis of the EoL-1 cell line. Apoptosis was shown in the nanomolar concentration range by phosphatidylserine externalization, proapoptotic shift of the Bcl-2/Bak ratio, drop in mitochondrial membrane potential, activation of caspases, and cellular morphology. Unlike in other ATRA-sensitive myeloid leukemia models, apoptosis was rapid and was not preceded by terminal cell differentiation. Use of isoform-selective synthetic retinoids indicated that retinoic acid receptor-alpha-dependent signaling is sufficient to induce apoptosis of EoL-1 cells. Our work shows that the scope of ATRA-induced apoptosis of malignancies may be wider within the myeloid lineage than thought previously, that the EoL-1 cell line constitutes a new and unique model for the study of ATRA-induced cell death, and that ATRA may have potential for the management of clonal HES.lld:pubmed
pubmed-article:16778211pubmed:languageenglld:pubmed
pubmed-article:16778211pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16778211pubmed:citationSubsetIMlld:pubmed
pubmed-article:16778211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16778211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16778211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16778211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16778211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16778211pubmed:statusMEDLINElld:pubmed
pubmed-article:16778211pubmed:monthJunlld:pubmed
pubmed-article:16778211pubmed:issn0008-5472lld:pubmed
pubmed-article:16778211pubmed:authorpubmed-author:ChomienneChri...lld:pubmed
pubmed-article:16778211pubmed:authorpubmed-author:PappBélaBlld:pubmed
pubmed-article:16778211pubmed:authorpubmed-author:BalitrandNico...lld:pubmed
pubmed-article:16778211pubmed:authorpubmed-author:DelvaLaurentLlld:pubmed
pubmed-article:16778211pubmed:authorpubmed-author:NahajevszkySa...lld:pubmed
pubmed-article:16778211pubmed:authorpubmed-author:RobertCarineClld:pubmed
pubmed-article:16778211pubmed:authorpubmed-author:MassziTamàsTlld:pubmed
pubmed-article:16778211pubmed:issnTypePrintlld:pubmed
pubmed-article:16778211pubmed:day15lld:pubmed
pubmed-article:16778211pubmed:volume66lld:pubmed
pubmed-article:16778211pubmed:ownerNLMlld:pubmed
pubmed-article:16778211pubmed:authorsCompleteYlld:pubmed
pubmed-article:16778211pubmed:pagination6336-44lld:pubmed
pubmed-article:16778211pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:meshHeadingpubmed-meshheading:16778211...lld:pubmed
pubmed-article:16778211pubmed:year2006lld:pubmed
pubmed-article:16778211pubmed:articleTitleApoptosis induction by retinoids in eosinophilic leukemia cells: implication of retinoic acid receptor-alpha signaling in all-trans-retinoic acid hypersensitivity.lld:pubmed
pubmed-article:16778211pubmed:affiliationInstitut National de la Santé et de la Recherche Médicale, UMR-S 718, Institut Universitaire d'Hématologie, University of Paris VII, Paris, France.lld:pubmed
pubmed-article:16778211pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16778211pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16778211lld:pubmed